Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Afya (AFYA) Cash & Equivalents (2018 - 2025)

Afya (AFYA) has disclosed Cash & Equivalents for 8 consecutive years, with $208.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 33.16% to $208.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $208.7 million through Dec 2025, up 33.16% year-over-year, with the annual reading at $208.7 million for FY2025, 33.16% up from the prior year.
  • Cash & Equivalents hit $208.7 million in Q4 2025 for Afya, up from $156.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $208.7 million in Q4 2025 to a low of $111.7 million in Q4 2023.
  • Historically, Cash & Equivalents has averaged $163.8 million across 5 years, with a median of $156.8 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: surged 54.83% in 2022 and later tumbled 46.24% in 2023.
  • Year by year, Cash & Equivalents stood at $134.2 million in 2021, then soared by 54.83% to $207.8 million in 2022, then crashed by 46.24% to $111.7 million in 2023, then skyrocketed by 40.33% to $156.8 million in 2024, then soared by 33.16% to $208.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for AFYA at $208.7 million in Q4 2025, $156.8 million in Q4 2024, and $111.7 million in Q4 2023.